[ad_1] SINGAPORE, Nov. 2, 2023 /PRNewswire/ — At the annual Singapore Week of Innovation and Technology (SWITCH) 2023, Lion TCR, a clinical-stage mRNA-based T cell immunotherapy company, is thrilled to…
Tag: Medical Pharmaceuticals
QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System
[ad_1] Partnership combines QIAGEN’s QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element’s AVITI System users in genomic analysis Element and QIAGEN are advancing genomic applications with innovative technology…
enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company
[ad_1] Business combination transaction completed with Forbion European Acquisition Corp. Clinical stage biotechnology company with EG-70 lead program in pivotal clinical study targeting BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) $138M…
AUNA PROVIDES UPDATE ON CAPITAL STRUCTURE INITIATIVES
[ad_1] LUXEMBOURG CITY, Luxembourg, Oct. 25, 2023 /PRNewswire/ — Auna S.A. (“Auna” or the “Company”) intends to confidentially submit a draft registration statement on Form F-1 to the U.S. Securities…
Crum & Forster Accident & Health Names Joseph Muccia Chief Financial Officer
[ad_1] EATONTOWN, N.J., Oct. 24, 2023 /PRNewswire/ — Crum & Forster’s (C&F) Accident & Health (A&H) Division announces the promotion of Joseph (Joe) Muccia to Chief Financial Officer, A&H Division. Joe previously…
Centinel Spine® Completes Divestment of its Spine Fusion Business to Silony Spine
[ad_1] The completed transaction includes the sale of all cervical and lumbar fusion products, including the STALIF® technology platform. In divesting its fusion portfolio, Centinel Spine will focus exclusively on…
Cardinal Health Named to 100 Best Corporate Citizens of 2023
[ad_1] DUBLIN, Ohio, Oct. 18, 2023 /PRNewswire/ — Cardinal Health (NYSE: CAH) has been named among the 100 Best Corporate Citizens, a prestigious annual ranking by 3BL Media that assesses the environmental,…
Brainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention
[ad_1] Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics OXFORD, England, Oct. 12, 2023 /PRNewswire/ — Brainomix Ltd, an AI-powered medtech solutions company, and Nanoflex Robotics AG, a…
Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals
[ad_1] – Alar’s Lead Asset ALA-1000 Potentially is the First Three-Month LAI Treatment for OUD – RICHMOND, Va., Oct. 11, 2023 /PRNewswire/ — Indivior PLC (LSE/Nasdaq: INDV), a leading addiction treatment company,…
Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta
[ad_1] PALO ALTO, Calif., Sept. 12, 2023 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases, today announced its…